Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings

NCT02867748 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT02867748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
March 31, 2019
Enrollment
99 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

urinary stress incontinence